November 2026
- Aspirin Therapy — Enough after Arthroplasty?
- Case 32-2026: A 50-Year-Old Man with Recurrent Cardiomyopathy
- Autoantibodies against Type I Interferons and Death from H7N7 Avian Influenza
- Perioperative Apalutamide in High-Risk Localized Prostate Cancer
- Interferon-γ Underlying Thymoma-Associated Immune Dysregulation
- Subretinal Gene Therapy in X-Linked Retinoschisis
- Iptacopan in IgA Nephropathy — Final 24-Month Data
- Preventing Malaria Infections and Moving toward Malaria Elimination
- High-Flow Oxygen Therapy with Nasal Cannula
- Lung Hernia with a Chest-Wall Bulge
- Prevention of Venous Thromboembolism after Total Hip or Knee Replacement
- Intismeran Autogene plus Pembrolizumab for Resected Stage IIB to IV Melanoma
- Cancer Vaccines — From Treatment to Prevention
- ANGPTL4 Inhibition in Adults with Elevated Triglyceride Levels
- Community and EMS Interventions to Improve Survival in Cardiac Arrest
- Left Bundle-Branch Pacing versus Right Ventricular Pacing for Atrioventricular Block
- A Liver-Targeted CIDEB siRNA in Adults with MASLD
- Retatrutide Once Weekly in Adults with Knee Osteoarthritis Pain and Obesity
- Equity in Maternal–Fetal Medicine — Technological Advances and a Potential Path Forward
- Early Days, Late Nights
- Lung Hernia with a Chest-Wall Hematoma
- Mass Surveillance with Artificial Intelligence — A New Determinant of Health?
- Intensive Blood-Pressure Lowering in Patients with Type 2 Diabetes
- Discontinuing Statins in Older Adults without Cardiovascular Disease
- Intensive Blood-Pressure Control in Patients with Previous Ischemic Stroke
- Prehospital Extracorporeal Life Support in Refractory Out-of-Hospital Cardiac Arrest
- Bringing Rapid Reperfusion to More Patients with Out-of-Hospital Cardiac Arrest
- Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)
- Interleukin-6 Inhibition with Ziltivekimab for Atherosclerotic Disease
- Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition
- TAVR in Patients with Moderate Aortic Stenosis with At-Risk Features
- Management of Moderate Aortic Stenosis in Older Adults — The P in PICOT
- Coronary CT Angiography versus Intravascular Ultrasound Guidance for PCI
- Extended Outcomes of the ADAPT AF-DES Trial
- In Vitro Fertilization or Intrauterine Insemination in Unexplained Infertility
- Sacituzumab Tirumotecan plus Pembrolizumab in PD-L1–Negative Advanced NSCLC
- Osimertinib–Savolitinib in Advanced NSCLC after Progression during EGFR-TKI Therapy
- Divarasib as Compared with Sotorasib or Adagrasib in KRAS G12C–Mutated NSCLC
- Anbenitamab plus HB1801 for HER2-Positive Advanced Breast Cancer
- Targeting HER2 — A Triumph of Science
- Tarlatamab–Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer
- Durvalumab, Tremelimumab, and Enfortumab Vedotin in Muscle-Invasive Bladder Cancer
- Expanding the Evidence and Indications for Thrombectomy in Ischemic Stroke
- Trial of Endovascular Therapy for Mild Stroke with Large-Vessel Occlusion
- Mechanical Thrombectomy 24 to 72 Hours after Large-Vessel Ischemic Stroke
- Ravulizumab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
- Sibeprenlimab in IgA Nephropathy — Final Phase 3 Trial Analysis
- Atacicept in IgA Nephropathy — Phase 3 Trial Final Efficacy Analysis
- Retatrutide Once Weekly for Treatment of Obstructive Sleep Apnea
- Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes